Nasopharyngeal News and Research

RSS

Houston Methodist researchers join national consortium to develop herpesvirus vaccine

Houston Methodist researchers will be part of a national consortium funded by an up to $49 million award from the U.S. Government's Advanced Research Projects Agency for Health (ARPA-H) to develop a vaccine against two of the most common and destructive strains of herpesviruses that latently infect a majority of Americans and can lead to acute infections, multiple forms of cancer, autoimmune disease and birth defects.

3 Oct 2024

COVID-19 linked to increased risk of hearing loss in young adults, study finds

Researchers in South Korea found that young adults who recovered from COVID-19 are at significantly higher risk of experiencing hearing loss and sudden sensorineural hearing loss compared to those who never had the virus.

28 Aug 2024

Does cannabis use disorder increase the risk of head and neck cancer?

Researchers determine whether cannabis use disorder increases the risk of head and neck cancer.

12 Aug 2024

Saliva test outperforms blood test in indicating the severity of recurrent respiratory infections in children

A saliva test can more accurately indicate the severity of recurrent respiratory infections in children than the standard blood test.

8 Aug 2024

Upper respiratory microbiome shows age, sex, and lifestyle impacts, study finds

A Dutch study analyzed the upper respiratory tract microbiome across various age groups, finding significant associations between microbial composition, age, sex, and lifestyle factors like smoking and antibiotic use.

5 Aug 2024

H5N1 avian flu found in Texas dairy cattle and milk, sparking concerns about underreported infections

Researchers at UTMB found H5N1 avian influenza virus in Texas dairy cattle and milk, highlighting potential underreporting of infections among farm workers and the need for better surveillance.

4 Aug 2024

COVID-19 significantly increases risk of hearing loss in young adults, study finds

Young adults with COVID-19 face a significantly higher risk of hearing loss and sudden sensorineural hearing loss. Researchers urge awareness and further investigation into COVID-19-related auditory damage.

31 Jul 2024

Wildlife species show high SARS-CoV-2 exposure linked to human activity

Researchers found SARS-CoV-2 RNA in six wildlife species and higher seroprevalence in high human activity areas. Seven new human-to-animal transmission events of the Omicron variant were identified.

30 Jul 2024

Study identifies RFC4 as key player in nasopharyngeal carcinoma

Lichuan Wu et al., at Medical College of Guangxi University, China, presented a comprehensive study on the role of replication factor C subunit 4 (RFC4) in nasopharyngeal carcinoma (NPC), a type of epithelial cancer commonly associated with Epstein-Barr virus infection.

12 Jul 2024

Frequent infections and pathobionts boost children's nasal immunity, study reveals

Dynamic interactions with viruses and bacterial pathobionts significantly enhance nasal innate immunity in children, revealing distinct immunophenotypes driven by microbial load and type.

2 Jul 2024

Study reveals early immune responses to SARS-CoV-2, offering insights for future COVID-19 treatments

Researchers analyzed early immune responses to SARS-CoV-2 using single-cell multi-omics, revealing key cellular states associated with different infection outcomes.

24 Jun 2024

New approach reduces the required drug dosage for cancer treatment

Traditional chemotherapy often poses significant challenges, including severe side effects, damage to healthy tissue and limited efficacy.

6 Jun 2024

UCSF to lead first long-term study of cancer among Asian Americans

UC San Francisco researchers have received $12.45 million from the National Cancer Institute (NCI) to lead the first long-term study of cancer among Asian Americans, a highly diverse yet understudied group.

22 May 2024

Research highlights emergence of immune-evasive SARS-CoV-2 variants in immunocompromised patients

New research to be presented at next week's ESCMID Global Congress (formerly ECCMID) in Barcelona, Spain (27-30 April) highlights the risk of new immune-evasive SARS-CoV-2 variants emerging in immunocompromised patients.

18 Apr 2024

Research confirms no association between SARS-CoV-2 and childhood asthma diagnoses

Whether severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection influences children's asthma risk.

16 Apr 2024

Study links pneumonia transmission in seniors to contact with young children

New research being presented at this year's European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2024) in Barcelona, Spain (27-30 April) finds that pneumonia-causing bacteria are common in the over 60s and that contact with pre-school and young school-aged children appears to be the most important factor in the onward transmission of Streptococcus pneumoniae (pneumococcus) to the over 60s.

3 Apr 2024

NIH study uncovers vulnerable sites on Epstein-Barr virus protein

Studies of interactions between two lab-generated monoclonal antibodies (mAbs) and an essential Epstein-Barr virus (EBV) protein have uncovered targets that could be exploited in designing treatments and vaccines for this extremely common virus.

12 Mar 2024

SARS-CoV-2-infection and vaccine-induced antibodies wane initially but stabilize for lasting protection

A study published in Immunity shows that antibody responses to SARS-CoV-2 infection and vaccination are long-lasting, with an initial decline followed by stabilization after seven to nine months, highlighting the effectiveness of mRNA vaccines and the importance of hybrid immunity.

25 Feb 2024

Chewing tobacco linked to higher stroke and cancer risk, study finds

Chewing tobacco significantly increases the risk of strokes and several types of cancer, revealing critical health implications for its 270 million global users.

7 Feb 2024

Netherlands sees unexpected surge in Mycoplasma pneumoniae cases, younger population more affected

A study in the Netherlands reports a significant rise in Mycoplasma pneumoniae infections since October 2023, with a notable decrease in the median age of patients compared to the last epidemic.

28 Jan 2024